Myriad Genetics (NASDAQ:MYGN) Earnings Information
Myriad Genetics last posted its earnings data on February 22nd, 2021. The reported ($0.12) earnings per share for the quarter, hitting the consensus estimate of ($0.12). The business earned $154.60 million during the quarter, compared to analysts' expectations of $148.11 million. Its revenue for the quarter was down 20.8% compared to the same quarter last year. Myriad Genetics has generated ($0.35) earnings per share over the last year. Myriad Genetics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 4th, 2021 based off prior year's report dates.
Myriad Genetics Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Myriad Genetics (NASDAQ:MYGN) Earnings Estimates
2021 EPS Consensus Estimate: ($0.12)
Myriad Genetics (NASDAQ MYGN) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)